Psyence Biomedical Ltd. (PBM)
4.20
-0.13
(-3.00%)
USD |
NASDAQ |
Aug 24, 16:00
4.20
0.00 (0.00%)
After-Hours: 20:00
Psyence Biomedical Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2025 | 0.00 |
| September 30, 2024 | -0.0385 |
| September 30, 2023 | -0.4598 |
| June 30, 2023 | 0.806 |
| March 31, 2023 | 0.4494 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -1.653 |
| June 30, 2021 | -9.585 |
| March 31, 2021 | 1.654 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 0.0052 |
| Aurinia Pharmaceuticals, Inc. | 0.1043 |
| enGene Therapeutics, Inc. | 0.1307 |
| Medicus Pharma Ltd. | -12.27 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 12.81M |
| Total Liabilities (Quarterly) | 0.9431M |
| Shareholders Equity (Quarterly) | 11.87M |